Hepatitis C News and Research

Latest Hepatitis C News and Research

Global drug research programme comes to Diamond in Oxfordshire

Diamond has announced that USA-based global biotechnology company Vertex Pharmaceuticals Incorporated is the first industrial user at the UK's world class new research facility, Diamond Light Source

27 May 2008

Summit to tackle African-American HIV/STD crisis

Black state board of education leaders from across the nation will meet to strategize about ways in which public schools can help address the HIV and STD crises among African-Americans and to highlight the clear link between risky sexual behaviors and academic performance on May 28-30, 2008 in Atlanta, Georgia.

22 May 2008

HIV/AIDS advocacy groups protest ruling in case regarding HIV-positive man, saliva

Several HIV/AIDS advocacy groups are saying that a recent ruling in a Dallas County, Texas, case that an HIV-positive man who spit into the mouth and eye of a Dallas police officer was using saliva as a deadly weapon was excessive, the Dallas Morning News reports.

20 May 2008

Scientists paint-viruses with proteins to track and treat viral disease and evolution

Biologists from Austria and Singapore developed a technique that adds a new twist on the relationship between biology and art. In an article recently published online in The FASEB Journal and scheduled for the August 2008 print issue, these researchers describe how they were able to coat-or paint-viruses with proteins.

20 May 2008

Warning about lack of attention given to hepatitis

A report by the World Hepatitis Alliance has called for an increased focus on hepatitis and says the disease should be given the same attention as AIDS, tuberculosis and malaria.

20 May 2008

New theory suggests how hepatitis C may cause rare immune disease

Of the hepatitis alphabet, the C variant may be the nastiest. In 1990, researchers observed that most patients with hepatitis C also develop a rare autoimmune disease called mixed cryoglobulinemia, a condition that frequently leads to cancer, arthritis or both.

10 May 2008

microRNAs appear essential for retinal health

Retinas in newborn mice appear perfectly fine without any help from tiny bits of genetic material called microRNAs except for one thing - the retinas do not work.

7 May 2008

Relief in sight for arthritis triggered by viral infections such as Ross River fever

Australian scientists believe they may have discovered the possibility of relief for those suffering with the debilitating arthritis triggered by viral infections such as Ross River fever.

6 May 2008

Enterovirus 71 in China claims the lives of two more children

The World Health Organisation (WHO) has warned that a virus that has killed 24 young children and infected more than 5,000 could continue to spread regardless of efforts to contain it.

5 May 2008

Expert says solve kidney donor crisis by paying for organs

A senior medical specialist has caused controversy over his comments regarding organ donations.

5 May 2008

Stanford researchers synthesize new agents to flush HIV out of hiding

Any hunter will tell you that when your quarry goes into hiding, you have to flush it out to get a good shot at it. Such is the case with HIV, the virus that causes AIDS.

1 May 2008

CDC says one in four children are out of compliance with U.S. vaccination guidelines

Your toddler might be improperly vaccinated, even if she's had every immunization the government recommends, according to a new study from the Centers for Disease Control and Prevention.

29 Apr 2008

Iowa records 127 new HIV cases in 2007, highest number since 1998, health department report says

Iowa recorded 127 new HIV cases in 2007, a 12% increase from the 113 cases reported in 2006 and the highest number since the state began recording HIV/AIDS cases in 1998, according to a recently released Iowa Department of Public Health report, the Cedar Rapids Gazette reports.

26 Apr 2008

Hepatitis C therapy peginterferon alfa-2b shows promise

The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).

24 Apr 2008

Independent examines U.K. insurers' practices regarding MSM, risk of HIV

London's Independent on Saturday examined the practices of some insurance companies in the United Kingdom regarding men who have sex with men who are applying for policies for life insurance or major illnesses.

22 Apr 2008

Number of HIV-positive state and federal inmates drops

Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent -- from 22,676 to 21,980 inmates, according to a report by the Justice Department's Bureau of Justice Statistics (BJS). Another BJS report estimated that 44 percent of state inmates and 39 percent of federal inmates reported a current medical problem other than a cold or a virus.

22 Apr 2008

New York Times examines increasing prices of specialty drugs distributed exclusively by pharmacy benefit managers

The New York Times on Saturday examined how pharmacy benefit managers in recent years "have built lucrative side businesses ... acting as exclusive or semi-exclusive distributors of expensive specialty drugs."

21 Apr 2008

South Carolina House to consider bill that would eliminate requirement to inform school officials of students' HIV-positive status

The South Carolina House this week is scheduled to consider a bill (SB 970) that would eliminate a state law that requires the Department of Health and Environmental Control to notify school district superintendents and nurses if students test HIV-positive, the Columbia State reports.

21 Apr 2008

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

21 Apr 2008

Prioritise patients, not privatisation

UNISON is calling on NHS trusts across England to refocus on patients, after the government's health watchdog revealed the findings of its latest staff survey.

10 Apr 2008